NCT07198256 AI-assisted Diagnosis of Malignant Brain Tumors
| NCT ID | NCT07198256 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine |
| Condition | Gliomas |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2025-09-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to establish a large-scale, multi-center MRI database for malignant brain tumors. It will develop an artificial intelligence system for the segmentation and classification of multiple subtypes of brain tumors (including glioma, metastatic tumor and lymphoma et al.) using deep learning technology. This will address the issues of small sample sizes and limited classification performance in existing methods, thereby improving the accuracy of non-invasive preoperative diagnosis, reducing the need for biopsies, and having significant clinical translational value.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with glioma, brain metastases, and brain lymphoma by pathology, with the patient being at least 18 years old; preoperative MRI was complete. Exclusion Criteria: * Poor image quality; history of previous brain surgery or radiotherapy; accompanied by other intracranial lesions.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07198256 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Gliomas. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07198256 currently recruiting?
Yes, NCT07198256 is actively recruiting participants. Contact the research team at wangchaosmart@zju.edu.cn for enrollment information.
Where is the NCT07198256 trial being conducted?
This trial is being conducted at Hangzhou, China, Hangzhou, China.
Who is sponsoring the NCT07198256 clinical trial?
NCT07198256 is sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine. The trial plans to enroll 3,000 participants.